首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1623959

小動物體內成像市場規模、佔有率、成長分析、按模式、按試劑、按應用、按最終用戶、按地區 - 產業預測，2025-2032 年

Small Animal Imaging In Vivo Market Size, Share, Growth Analysis, By Modality, By Reagents, By Application, By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月03日 | 出版商:

SkyQuest | 英文 224 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023年，全球小動物體內影像市場規模為10.7億美元，從2024年的11.5億美元成長到2032年的21億美元，在預測期間（2025-2032年）預計將以年複合成長率為7.8 %。

隨著微型 MRI、微型 CT、微型 PET、多模態成像等微型儀器以及微型超音波和光學成像等新興技術的進步，核醫學成像技術市場正在不斷發展。市場成長的主要驅動力包括不斷增加的藥品投資和臨床前研究需求。然而，它們面臨嚴格監管和報銷不足的挑戰，特別是在基礎設施和熟練人力資源不足的新興經濟體。由於有利的報銷政策和對先進成像系統的大量投資，北美佔據全球市場 35% 的佔有率。另一方面，亞太地區預計將以11.5%的複合年成長率穩定成長。 COVID-19 大流行暫時擾亂了供應鏈和需求，影響了市場動態。總體而言，負擔得起的技術商業化對於產業擴張仍然至關重要。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2022-2024）

主要企業簡介

Bruker Corporation（US）
PerkinElmer, Inc.（US）
FUJIFILM Holdings Corporation（Japan）
Siemens Healthineers AG（Germany）
Miltenyi Biotec（Germany）
Aspect Imaging（Israel）
Thermo Fisher Scientific Inc.（US）
GE Healthcare（US）
Mediso Ltd.（Hungary）
MR Solutions Ltd.（UK）
TriFoil Imaging（US）
Key Developments
Agilent Technologies, Inc.（US）
Hitachi Ltd.（Japan）
Canon Medical Systems Corporation（Japan）

結論和建議

簡介目錄

Product Code: SQSG35A2089

Global Small Animal Imaging In Vivo Market size was valued at USD 1.07 billion in 2023 and is poised to grow from USD 1.15 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The nuclear imaging technology market is evolving with advancements in micro-level equipment, including micro MRI, micro CT, and micro PET, as well as multimodal imaging and emerging techniques like micro-ultrasound and optical imaging. Key drivers of market growth include increasing pharmaceutical investments and pre-clinical research needs. However, stringent regulations and inadequate reimbursement pose challenges, particularly in developing economies with insufficient infrastructure and skilled personnel. North America leads, dominating the global market with a 35% share due to favorable reimbursement policies and significant investments in advanced imaging systems. Meanwhile, the Asia-Pacific region is anticipated to experience robust growth at a CAGR of 11.5%. The COVID-19 pandemic has temporarily disrupted supply chains and demand, impacting market dynamics. Overall, affordable technology commercialization remains crucial for industry expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Animal Imaging In Vivo market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Animal Imaging In Vivo Market Segmental Analysis

Global Small Animal Imaging In Vivo Market is segmented by Modality, Reagents, Application, End-User and region. Based on Modality, the market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, Ultrasound Imaging Systems and Photoacoustic Imaging Systems. Based on Reagents, the market is segmented into Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents. Based on Application, the market is segmented into Biodistribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Drug Development and Functional and Anatomical Imaging. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs) and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Small Animal Imaging In Vivo Market

The global Small Animal Imaging In Vivo market is poised for growth driven by several key factors. The increasing adoption of multimodal imaging technologies is anticipated to significantly enhance market expansion throughout the forecast period. Additionally, rising healthcare expenditures are expected to bolster the small animal imaging sector. The preference for non-invasive imaging solutions is also gaining traction, further propelling market growth. Contributing factors include higher disposable incomes and urbanization trends, which create a more conducive environment for technological advancements. Furthermore, the growing investment in healthcare infrastructure is a significant driving force, particularly in oncology applications, as cancer rates rise worldwide.

Restraints in the Global Small Animal Imaging In Vivo Market

The growth of the small animal in vivo imaging market is anticipated to be hampered by several factors during the projected period. Key restraints include the high costs associated with imaging equipment and existing technological limitations. Additionally, there is a significant shortage of skilled professionals in emerging markets, compounded by insufficient research facilities and infrastructure. The market will also encounter challenges due to low healthcare expenditure in developing countries and the absence of standardized practices. Furthermore, limited awareness and a scarcity of qualified experts will constrain the overall growth rate of the small animal imaging sector from 2022 to 2028.

Market Trends of the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market is experiencing significant growth driven by the surging demand for non-invasive imaging techniques. This trend is propelled by the expansion of pharmaceutical companies and research institutions, bolstered by funding from public and private sectors for innovative developments. Moreover, advancements across multiple disciplines such as chemistry, computer science, engineering, medicine, and molecular biology are enhancing imaging capabilities. The period from 2021 to 2028 is expected to witness further opportunities, particularly due to rising demand in emerging economies and intensified R&D initiatives, positioning the market for sustained expansion and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape

Global Small Animal Imaging In Vivo Market Size by Modality & CAGR (2025-2032)

Market Overview
Optical Imaging Systems
- Bioluminescence Imaging
- Fluorescence Imaging
Nuclear Imaging Systems
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
Magnetic Resonance Imaging (MRI) Systems
Computed Tomography (CT) Systems
Ultrasound Imaging Systems
Photoacoustic Imaging Systems

Global Small Animal Imaging In Vivo Market Size by Reagents & CAGR (2025-2032)

Market Overview
Optical Imaging Reagents
Nuclear Imaging Reagents
MRI Contrast Agents
Ultrasound Contrast Agents
CT Contrast Agents

Global Small Animal Imaging In Vivo Market Size by Application & CAGR (2025-2032)

Market Overview
Biodistribution Studies
Cancer Cell Detection
Biomarkers
Longitudinal Studies
Drug Development
Functional and Anatomical Imaging

Global Small Animal Imaging In Vivo Market Size by End-User & CAGR (2025-2032)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Hospitals and Clinics

Global Small Animal Imaging In Vivo Market Size & CAGR (2025-2032)

North America (Modality, Reagents, Application, End-User)
- US
- Canada
Europe (Modality, Reagents, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Modality, Reagents, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Modality, Reagents, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Modality, Reagents, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspect Imaging (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR Solutions Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriFoil Imaging (US)
- Company Overview
- Business Segment Overview
- Financial Updates
Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments